1-3 of 3
M. Hoogendoorn
Close
Sort by
Journal Articles

Improved T-Cell Chimerism and Successful Withdrawal of Immunosuppression after Non-Myeloablative Stem Cell Transplantation for Sickle Cell Disease with Azathioprine/Hydroxyurea Preconditioning Added to Alemtuzumab/TBI Conditioning

Elisabeth Dovern, Mesire Aydin, Man Wai Tang, Liesbeth E.M. Suijk, Gerianne M. Hoogendoorn, Charlotte F.J. Van Tuijn, Jean-Louis Kerkhoffs, Caroline E. Rutten, Sacha S. Zeerleder, Mette D. Hazenberg, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 10476–10477.
https://doi.org/10.1182/blood-2022-159390
Published: 2022
Journal Articles

Primary Allogeneic T-Cell Responses Against In Vitro Modified Mantle Cell Lymphoma (MCL) Cells: Implications for Adoptive Immunotherapy after HLA-Matched Stem Cell Transplantation (SCT).

M. Hoogendoorn, MD, J. Olde Wolbers, W. M. Smit, MD PhD, I. Jedema, PhD, M. R. Schaafsma, MD PhD, R. M.Y. Barge, MD PhD, R. Willemze, MD PhD, J. H.F. Falkenburg, MD PhD
Journal: Blood
Blood (2004) 104 (11): 2118.
https://doi.org/10.1182/blood.V104.11.2118.2118
Published: 2004
Journal Articles

Depletion of In-Vivo Activated Regulatory T Cells Followed by Synchronized Specific In-Vitro Activation Allows the Rapid Isolation of Leukemia-Reactive T Cells for Immunotherapy.

I. Jedema, E. Steeneveld, M. Hoogendoorn, R. Willemze, J.H.F. Falkenburg
Journal: Blood
Blood (2004) 104 (11): 297.
https://doi.org/10.1182/blood.V104.11.297.297
Published: 2004